FR2373280A1 - Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation - Google Patents

Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation

Info

Publication number: FR2373280A1
Authority: FR; France
Prior art keywords: pyrrolidino; phenoxy; active substance; preparation process; new form
Prior art date: 1976-12-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

FR7736876A

Other languages

English (en)

French (fr)

Other versions

FR2373280B1 (da

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hoechst AG

Original Assignee

Hoechst AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-12-07

Filing date

1977-12-07

Publication date

1978-07-07

1977-12-07 Application filed by Hoechst AG filed Critical Hoechst AG

1978-07-07 Publication of FR2373280A1 publication Critical patent/FR2373280A1/fr

1980-06-20 Application granted granted Critical

1980-06-20 Publication of FR2373280B1 publication Critical patent/FR2373280B1/fr

Status Granted legal-status Critical Current

Links

238000002360 preparation method Methods 0.000 title 1
239000013543 active substance Substances 0.000 abstract 3
239000007853 buffer solution Substances 0.000 abstract 2
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 1
UJEWTUDSLQGTOA-UHFFFAOYSA-N Piretanide Chemical compound C=1C=CC=CC=1OC=1C(S(=O)(=O)N)=CC(C(O)=O)=CC=1N1CCCC1 UJEWTUDSLQGTOA-UHFFFAOYSA-N 0.000 abstract 1
229920001800 Shellac Polymers 0.000 abstract 1
235000021355 Stearic acid Nutrition 0.000 abstract 1
230000002378 acidificating effect Effects 0.000 abstract 1
229920002678 cellulose Chemical class 0.000 abstract 1
239000001913 cellulose Chemical class 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
230000003111 delayed effect Effects 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
229960001085 piretanide Drugs 0.000 abstract 1
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 abstract 1
229940113147 shellac Drugs 0.000 abstract 1
235000013874 shellac Nutrition 0.000 abstract 1
239000004208 shellac Substances 0.000 abstract 1
239000008117 stearic acid Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

FR7736876A 1976-12-07 1977-12-07 Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation Granted FR2373280A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19762655331 DE2655331A1 (de)	1976-12-07	1976-12-07	Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung

Publications (2)

Publication Number	Publication Date
FR2373280A1 true FR2373280A1 (fr)	1978-07-07
FR2373280B1 FR2373280B1 (da)	1980-06-20

Family

ID=5994862

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR7736876A Granted FR2373280A1 (fr)	1976-12-07	1977-12-07	Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation

Country Status (15)

Country	Link
JP (1)	JPS5372815A (da)
AT (1)	AT355216B (da)
AU (1)	AU513409B2 (da)
BE (1)	BE861608A (da)
DE (1)	DE2655331A1 (da)
DK (1)	DK542877A (da)
ES (1)	ES464642A1 (da)
FR (1)	FR2373280A1 (da)
GB (1)	GB1569018A (da)
IE (1)	IE46005B1 (da)
IL (1)	IL53539A0 (da)
NL (1)	NL7713392A (da)
NZ (1)	NZ185855A (da)
PT (1)	PT67370B (da)
ZA (1)	ZA777204B (da)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0260236A1 (en) *	1986-08-26	1988-03-16	ASTA Pharma Aktiengesellschaft	Composition comprising L-dopa
EP0243891A3 (en) *	1986-04-29	1988-08-03	Hoechst-Roussel Pharmaceuticals Incorporated	A laminar structure for administering a chemical at a controlled release rate
WO1996026197A1 (en) *	1995-02-22	1996-08-29	Hoechst Pharmaceuticals & Chemicals K.K.	Amorphous piretanide, piretanide polymorphs, process for their preparation and their use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1964504A1 (de) *	1968-12-24	1970-07-09	Leo Pharm Prod Ltd	Arzneimittelzubereitung mit einem Gehalt an 3-Butylamino-4-phenoxy-5-sulfamyl-benzoesaeure und deren Salzen

1976
- 1976-12-07 DE DE19762655331 patent/DE2655331A1/de active Pending
1977
- 1977-12-01 ES ES464642A patent/ES464642A1/es not_active Expired
- 1977-12-02 NL NL7713392A patent/NL7713392A/xx not_active Application Discontinuation
- 1977-12-05 ZA ZA00777204A patent/ZA777204B/xx unknown
- 1977-12-05 IL IL53539A patent/IL53539A0/xx unknown
- 1977-12-05 NZ NZ185855A patent/NZ185855A/xx unknown
- 1977-12-06 DK DK542877A patent/DK542877A/da not_active Application Discontinuation
- 1977-12-06 PT PT67370A patent/PT67370B/pt unknown
- 1977-12-06 AT AT873777A patent/AT355216B/de not_active IP Right Cessation
- 1977-12-06 AU AU31274/77A patent/AU513409B2/en not_active Expired
- 1977-12-06 IE IE2474/77A patent/IE46005B1/en unknown
- 1977-12-07 JP JP14619077A patent/JPS5372815A/ja active Pending
- 1977-12-07 FR FR7736876A patent/FR2373280A1/fr active Granted
- 1977-12-07 GB GB50915/77A patent/GB1569018A/en not_active Expired
- 1977-12-07 BE BE183258A patent/BE861608A/xx unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1964504A1 (de) *	1968-12-24	1970-07-09	Leo Pharm Prod Ltd	Arzneimittelzubereitung mit einem Gehalt an 3-Butylamino-4-phenoxy-5-sulfamyl-benzoesaeure und deren Salzen

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0243891A3 (en) *	1986-04-29	1988-08-03	Hoechst-Roussel Pharmaceuticals Incorporated	A laminar structure for administering a chemical at a controlled release rate
EP0260236A1 (en) *	1986-08-26	1988-03-16	ASTA Pharma Aktiengesellschaft	Composition comprising L-dopa
WO1996026197A1 (en) *	1995-02-22	1996-08-29	Hoechst Pharmaceuticals & Chemicals K.K.	Amorphous piretanide, piretanide polymorphs, process for their preparation and their use
US6096779A (en) *	1995-02-22	2000-08-01	Hoechst Pharmaceuticals & Chemicals K.K.	Amorphous piretanide, piretanide polymorphs, process for their preparation and their use

Also Published As

Publication number	Publication date
ES464642A1 (es)	1978-09-01
PT67370B (de)	1979-09-20
BE861608A (fr)	1978-06-07
DE2655331A1 (de)	1978-06-08
IE46005L (en)	1978-06-07
ATA873777A (de)	1979-07-15
NZ185855A (en)	1979-10-25
ZA777204B (en)	1978-10-25
NL7713392A (nl)	1978-06-09
AU3127477A (en)	1979-06-14
AT355216B (de)	1980-02-25
DK542877A (da)	1978-06-08
PT67370A (de)	1978-01-01
AU513409B2 (en)	1980-11-27
FR2373280B1 (da)	1980-06-20
GB1569018A (en)	1980-06-11
JPS5372815A (en)	1978-06-28
IE46005B1 (en)	1983-01-26
IL53539A0 (en)	1978-03-10

Similar Documents

Publication	Publication Date	Title
US4804674A (en)	1989-02-14	Vaginal pharmaceutical composition
UY25067A1 (es)	2000-12-29	Acetato de sertralina, composiciones farmacéuticas que lo contienen y procedimientos de preparación.
BE901994A (fr)	1985-09-23	Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
DE1222213B (de)	1966-08-04	Spermizides Praeparat
GB1399985A (en)	1975-07-02	Hardening microcapsule walls
ES2117642T3 (es)	1998-08-16	Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
FR2364030A1 (fr)	1978-04-07	Compositions pharmaceutiques a base d'anthocyanidines et procede pour leur preparation
YU47422B (sh)	1995-03-27	Sredstvo sa asimetričnom membranom i postupak njenog dobijanja
TNSN98025A1 (fr)	2005-03-15	Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant.
ES2094539T3 (es)	1997-01-16	Preparacion farmaceutica y procedimiento para su preparacion.
BE901007A (fr)	1985-05-08	Comprimes pharmaceutiques a liberation etalee et procede pour les preparer.
ES8307491A1 (es)	1983-07-01	Un metodo para preparar una composicion de gel acuoso semi- solido para alimentacion de heridos
BE904476A (fr)	1986-09-24	Solutions a base de phenytoine, leur procede de preparation et leur application pharmaceutique.
FR2381521A1 (fr)	1978-09-22	Base pour des preparations medicamenteuses a usage externe, preparation medicamenteuses preparees a l'aide de celle-ci et procede pour leur preparation
BG51341A3 (bg)	1993-04-15	Метод за получаване на фармацевтичен състав
FR2461499A1 (fr)	1981-02-06	Composition pharmaceutique a base d'extraits de myrtille
BE752813A (fr)	1970-12-16	Preparation d'acide trans-chrysanthemique optiquement actif
FR2598320B1 (fr)	1990-11-02	Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
TNSN01115A1 (fr)	2005-11-10	Composition en particules contenant de l'eletriptan, et procede pour sa production
Abdul-Ghani et al.	1981	Effects of anticonvulsants on the in vivo and in vitro release of GABA
FR2358159A1 (fr)	1978-02-10	Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
FR2503149B1 (fr)	1985-07-26	Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
BE884848A (fr)	1981-02-20	Sel mixte d'acide valproique utile notamment pour le traitement de l'epilepsie, presentant des caracteristiques tres superieures de stabilite
TNSN99190A1 (fr)	2005-11-10	Composition pharmaceutique concentree liquide de sertraline et procede pour sa preparation
PT88145A (pt)	1989-06-30	Procede pour la preparation de composition pharmaceutique destinee a la prevention et au traitement des maladies bacteriennes ou virales

Legal Events

Date	Code	Title	Description
1983-12-16	TP	Transmission of property
1992-09-11	CC	Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)	Free format text: 92C0306, 920526
1992-11-20	CB	Supplementary protection certificate (spc) granted (law of 25 june 1990)	Free format text: 92C0306, 771207
1993-04-23	CL	Concession to grant licences